Rapid Tests for Assesment of TIA/Ischemic Stroke, Concussions & Risk of Posttraumatic Epilepsy
DRD (Diagnostic Reagents & Devices, DRD Ltd.)is research company, based in Republic Buryatia, Russia.
DRD Biotech develops and implements in vitro diagnostic devices - rapid tests based on innovative biotech and IT-technologies.
Rapid tests for assesment of:
Ischemic Stroke / TIA
Concussions and mild TBI
ELISA test kits for assesment of:
Risk of ischemic Stroke
Severity of brain damage after mild TBI
Our team has broad experience of the IVD market. DRD partners possess expertise in product development, regulatory and clinical affairs.
Company's consultants are recognized experts in the field of neurology, neurosurgery, development of biomarkers for brain damage, biotechnology, and clinical trials.
A concussion is a traumatic brain injury that alters the way how brain functions. The effect of a concussion is usually temporary and can be manifested in headaches, problems with concentration, memory, balance and coordination.
Concussions are common particularly in contact sport. Every concussion injures the brain to some extent and requests a time for brain to be healed properly. Most concussive injuries are mild, and people usually recover completely.
Mild traumatic brain injuries are most common among young people and persons of active age. Therefore medical and social costs to society can be significant. Depending on the severity of the injuries, persons may require medical attention and in some cases specialized care.
Currently, more than 2.0 million Russians are on long-term disability due to injury that amounts about 495 billion rubles, or 2.6% of GDP in annual economic loss to Russian healthcare system.